Fentanyl VL 100 mcg/2 mL (50 mcg/mL) 25-Count Vial
Key Features:
Strength: Each vial contains 100 mcg of fentanyl in 2 mL, providing a concentration of 50 mcg/mL.
Formulation: Sterile injectable solution for intravenous (IV) or intramuscular (IM) use.
Packaging: Supplied in a box with 25 vials, each containing 2 mL of solution.
Regulatory Status: Classified as a Schedule II (CII) controlled substance due to its potential for abuse and dependence.
Indication: Used for pain management, particularly in post-surgical settings or for patients who require opioid analgesia.
Storage: Store securely, as it is a controlled substance, and adhere to proper handling guidelines.
Administration: To be administered by trained healthcare professionals; titration is necessary to avoid overdose or respiratory depression.
Safety: Monitor for adverse effects, especially respiratory depression, and ensure compliance with regulatory requirements.
Description
Fentanyl VL (Injection) 100mcg/2mL (50mcg/mL) by Hikma is a potent synthetic opioid analgesic used for the management of severe pain, typically in patients undergoing surgery or in those requiring continuous opioid analgesia. As a powerful opioid, Fentanyl must be used with caution under strict medical supervision to avoid risks like respiratory depression, overdose, and other potentially dangerous side effects.
Each vial contains 100mcg of Fentanyl in 2mL of solution (50mcg/mL concentration), offering healthcare providers flexibility in dosing. This medication is intended for intravenous (IV) administration, ensuring rapid onset of pain relief. Fentanyl is a Schedule II (C2) controlled substance, which means it is subject to strict regulations and requires proper documentation, including DEA Form 222, for lawful distribution and handling.
This product comes in a box of 25 vials, providing a reliable supply for hospitals, clinics, and medical settings where high doses of potent analgesics are needed.
Key Features:
Strength: 100mcg per 2mL vial (50mcg/mL concentration)
Quantity: 25 vials per box for healthcare settings with significant patient needs
Indication: Primarily used for severe pain management in surgical procedures and chronic pain cases
Controlled Substance: Schedule II (C2) narcotic with DEA Form 222 required for distribution
Administration: Intravenous (IV) injection, to be administered by healthcare professionals only
Manufacturer: Hikma Pharmaceuticals, known for high-quality injectable medications
Storage and Handling: Must be stored securely as per regulatory standards for controlled substances
Dosage Flexibility: Provides adjustable dosing to meet individual patient needs for pain management
Safety: Requires close monitoring by trained medical personnel due to the potency and risks of opioid overdose

Reviews
There are no reviews yet.